BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 112662)

  • 1. The circumoval precipitin test as a control of cure in the experimental schistosomiasis mansoni.
    de Mello RT; Pereira LH; Pellegrino J
    Rev Inst Med Trop Sao Paulo; 1979; 21(1):1-4. PubMed ID: 112662
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose.
    da Silva LC; Sette Júnior H; Christo C; Sette PC; Kaye B
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):58-64, 175-81. PubMed ID: 7455511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of oxamniquine in Schistosoma mansoni bilharziasis in Madagascar in a hospital milieu].
    Queinnec J; Moyroud J
    Arch Inst Pasteur Madagascar; 1981; 48(1):143-9. PubMed ID: 7342891
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trial with oxamniquine and praziquantel in the acute and chronic phases of schistosomiasis mansoni.
    Katz N; Rocha RS; Lambertucci JR; Greco DB; Pedroso ER; Rocha MO; Flan S
    Rev Inst Med Trop Sao Paulo; 1983; 25(4):173-7. PubMed ID: 6361966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic evaluation of oxamniquine in schistosomiasis mansoni by the oogram method with biopsy of rectal mucosa].
    da Cunha AS
    Rev Inst Med Trop Sao Paulo; 1982; 24(2):88-94. PubMed ID: 6753086
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of UK 4271 (oxamniquine, Pfizer) in Schistosoma mansoni bilharziasis in western Africa (parasitological and serological study of 252 children)].
    Nozais JP; Geunier M
    Bull Soc Pathol Exot Filiales; 1979; 72(2):153-64. PubMed ID: 527159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind clinical trial comparing praziquantel with oxamniquine in schistosomiasis mansoni.
    Katz N; Rocha RS
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):310-4. PubMed ID: 6762634
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical development of oxamniquine in Egypt.
    Saif M; Gaber A
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):18-27, 134-43. PubMed ID: 7455504
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-blind clinical trial comparing praziquantel with oxamniquine in the treatment of patients with schistosomiasis mansoni.
    Branchini ML; Pedro Rde J; Dias LC; Deberaldini ER
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):315-21. PubMed ID: 6762635
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB; Asila J; Chimbe A
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Schistosoma mansoni prevalent in Saudi Arabia to oxamniquine in experimentally infected mice.
    Amin AM; Mikhail EG
    J Trop Med Hyg; 1988 Aug; 91(4):192-5. PubMed ID: 3136251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary report on the treatment of intestinal schistosomiasis with oxamniquine.
    Shafei AZ
    J Trop Med Hyg; 1979 Jan; 82(1):18-20. PubMed ID: 448786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase].
    Campos R; Pinto PL; Amato Neto V; Moreira AA
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosoma mansoni cationic egg antigens (CEF6): immunoserology with oxamniquine-treated patients and involvement of CEF6 in the circumoval precipitin reaction.
    Dunne DW; Hillyer GV; Vazquez G
    Am J Trop Med Hyg; 1988 May; 38(3):508-14. PubMed ID: 3152779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migration and fate of Schistosoma mansoni in mice treated with oxaminiquine.
    Oliveira MA; Pellegrino J; Pereira LH; Valadares TE
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):298-300. PubMed ID: 1006062
    [No Abstract]   [Full Text] [Related]  

  • 16. Field experiences with oral oxamniquine in the treatment of schistosomiasis mansoni.
    Coura JR; Argento CA; Conceição MJ; Lewis EM; dos Santos ML; Magalhães P
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):77-84, 195-202. PubMed ID: 7455514
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxamniquine in the treatment of various schistosome infections in South Africa.
    Pitchford RJ; Lewis M
    S Afr Med J; 1978 Apr; 53(17):677-80. PubMed ID: 354047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic evaluation of oxamniquine in schistosomiasis mansoni].
    de Almeida FM; Vilela MP; Pricoli TI; Salem N; Guimarães RX; Ferraz CN; Arroyo JB; Fukuda Y; Cabeca M; Geocze S; Tancredi Neto A
    AMB Rev Assoc Med Bras; 1979 Mar; 25(3):101-4. PubMed ID: 315583
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic-protective activity of oral oxamniquine against Schistosoma mansoni infection in hamsters.
    Girgis NI; Mansour NS; Kahlil SB
    East Afr Med J; 1979 Sep; 56(9):428-30. PubMed ID: 520260
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
    Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.